PLK1 and colorectal cancer: PLK1 inhibition using either siRNA or pharmacological inhibitors caused significant reductions in the invasiveness of glioblastoma, bladder carcinoma, renal cell carcinoma, anaplastic thyroid carcinoma, and colorectal cancer cells [45,48,49,99,100].